Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J D'Souza

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|October 29, 1986
Membrane-bound 5'-nucleotidase inhibitor in Ehrlich ascites tumour cells and newborn mouse liverS C Amruthesh, C J D'Souza
Mediators of Inflammation|January 1, 1993
Production of oxygen free radicals by Ehrlich ascites tumour cells: effect of lipidsG K Marathe, C J D'Souza
Indian Journal of Biochemistry & Biophysics|April 1, 1992
Isolation and characterization of 5'-nucleotidase inhibitor from rat liverA Rajput, B R Chakravarthy, C J D'Souza
Cell Biology International Reports|January 1, 1991
PAF-acether in AK-5 tumour cellsG K Marathe, T P Krishnakantha, C J D'Souza
Journal of Lipid Mediators|September 1, 1990
PAF-acether (PAF) in Ehrlich ascites tumour cellsG K Marathe, T P Krishnakanta, C J D'Souza
Biochimica Et Biophysica Acta|August 1, 1983
Studies on the turnover of endogenous choline-containing phospholipids of cultured neuroblastoma cellsC J D'Souza, J T Clarke, H W Cook, et al.
Journal of Proteome Research|September 30, 2010
Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentationNagarjuna Nagaraj, Rochelle C J D'Souza, Juergen Cox, et al.
Molecular & Cellular Proteomics : MCP|March 24, 2012
Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profilesSally J Deeb, Rochelle C J D'Souza, Jürgen Cox, et al.
Cell Reports|August 28, 2014
Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signalingKirti Sharma, Rochelle C J D'Souza, Stefka Tyanova, et al.
Acta Neuropathologica Communications|January 11, 2025
Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectivesNiclas Skarne, Rochelle C J D'Souza, Helen M Palethorpe, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|October 29, 1986
Membrane-bound 5'-nucleotidase inhibitor in Ehrlich ascites tumour cells and newborn mouse liverS C Amruthesh, C J D'Souza
Mediators of Inflammation|January 1, 1993
Production of oxygen free radicals by Ehrlich ascites tumour cells: effect of lipidsG K Marathe, C J D'Souza
Indian Journal of Biochemistry & Biophysics|April 1, 1992
Isolation and characterization of 5'-nucleotidase inhibitor from rat liverA Rajput, B R Chakravarthy, C J D'Souza
Cell Biology International Reports|January 1, 1991
PAF-acether in AK-5 tumour cellsG K Marathe, T P Krishnakantha, C J D'Souza
Journal of Lipid Mediators|September 1, 1990
PAF-acether (PAF) in Ehrlich ascites tumour cellsG K Marathe, T P Krishnakanta, C J D'Souza
Biochimica Et Biophysica Acta|August 1, 1983
Studies on the turnover of endogenous choline-containing phospholipids of cultured neuroblastoma cellsC J D'Souza, J T Clarke, H W Cook, et al.
Journal of Proteome Research|September 30, 2010
Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentationNagarjuna Nagaraj, Rochelle C J D'Souza, Juergen Cox, et al.
Molecular & Cellular Proteomics : MCP|March 24, 2012
Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profilesSally J Deeb, Rochelle C J D'Souza, Jürgen Cox, et al.
Cell Reports|August 28, 2014
Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signalingKirti Sharma, Rochelle C J D'Souza, Stefka Tyanova, et al.
Acta Neuropathologica Communications|January 11, 2025
Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectivesNiclas Skarne, Rochelle C J D'Souza, Helen M Palethorpe, et al.
Pageof 3